Axon Enterprise Inc vs Procter & Gamble Co — how do they compare? Axon Enterprise Inc trades at $633.93 (market cap $48.44B), while Procter & Gamble Co trades at $145 (market cap $340.39B). The key difference: Procter & Gamble Co is far larger — about 7× Axon Enterprise Inc's market cap, and Procter & Gamble Co pays a 2.97% dividend while Axon Enterprise Inc pays none. Which is the better fit depends on your goals.
| AXON | PG | |
|---|---|---|
Market Cap | $48.44B | $340.39B |
Sector | Technology | Consumer Staples |
52-Week High | $791.62 | $167.18 |
52-Week Low | $345.94 | $138.10 |
Enterprise Value | $49.59B | $366.23B |
Volume | — | 6,423,436 |
Dividend Yield | — | 2.97% |
Signals from Pluang's Aura AI — not financial advice
Axon Enterprise (AXON) trades at $571.01, up 9.29% with strong momentum following Q2 2026 results showing 35% revenue growth and 10 consecutive quarters above 30% expansion. Technical indicators show bullish moving averages with current price near resistance at $587. The company maintains dominant positioning in public safety technology with accelerating AI and counter-drone business segments driving future growth potential.
Axon presents compelling growth prospects with raised 2026 revenue guidance of 32-34% and expanding software ecosystem, though elevated valuations (P/E 248) and margin pressures from service mix shifts warrant caution. Analyst consensus remains strongly bullish with $685 price target representing 20% upside potential from current levels.
Procter & Gamble (PG) trades at $146.38, up 0.42% today, with a bearish technical signal but strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $1.90. Revenue reached $84.28B in 2025, with a net income margin of 18.44% and robust cash flow from operations of $17.82B. Analyst consensus is bullish with a $161.20 price target, though valuation multiples like P/E of 22.12 and P/S of 4.08 are at premiums to peers.
The outlook for PG is positive due to steady earnings growth and dividend reliability, but risks include premium valuation concerns and soft demand headwinds. Investors may find opportunity in its defensive qualities amid market volatility, though near-term upside could be limited by technical resistance and modest revenue growth projections.
Trailing returns across standard periods
Latest headlines on both assets
Axon develops technology and weapons for law enforcement and military use. Its ecosystem includes TASER devices, body cameras, and Evidence.com, a cloud-based platform for digital evidence management.
Read more on AXON →The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →